Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.
about
Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study.CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model systemAssociation of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysisGlycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.Catechol O-methyltransferase pharmacogenomics: human liver genotype-phenotype correlation and proximal promoter studies.Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.Germline predictors of androgen deprivation therapy response in advanced prostate cancerCatechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancerEffect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancerGenetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndromeNo association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters.The effect of catechol-O-methyltransferase polymorphisms on pain is modified by depressive symptoms.Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer
P2860
Q33742262-4CED8719-9B15-4597-BC02-D4FA91DF64CEQ33940572-C6EFDE3C-D02F-465D-A4FA-465EB5015AC4Q34435081-8337CDCE-1ACF-4636-A726-03548DA2F709Q34555598-517C230B-1AB4-4A30-B3BD-01946038DFDBQ34642640-B9B0B2D6-2AF1-4D7F-A106-D4B243273901Q35040545-13E42A1F-44A2-4B07-AA25-81E1443641C7Q35558999-0D32DE4A-D90A-413F-AA9D-1CCB48E14A2CQ35675274-E3C4FEDC-00E7-4C29-9F86-1A81103B2A69Q36512896-4A0B9408-70F2-48BC-A9E1-6236E4770754Q36880574-ED9D7D2B-D053-4FED-ABD3-03B495E2BF43Q36906731-96DDF1A3-C931-47F6-B182-EAF2270C82F6Q37266030-1FA434DF-6A24-4052-A962-F3AF33532F97Q37397324-E36D979C-EB7C-4503-B6E6-41743B3F7BF0Q39003605-20627578-236A-4893-BF42-713B39A3E585Q39270832-697B0F64-2F3A-40A0-9F3C-3CC7DFDDABA5Q48730311-7935CBFB-7FDC-4622-88AE-C702F92BE428Q57105341-AD7B46A0-9B14-40E3-BCF5-7CDEA1227935
P2860
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Breast cancer risk reduction a ...... sferase genetic polymorphisms.
@en
type
label
Breast cancer risk reduction a ...... sferase genetic polymorphisms.
@en
prefLabel
Breast cancer risk reduction a ...... sferase genetic polymorphisms.
@en
P2093
P2860
P50
P1433
P1476
Breast cancer risk reduction a ...... sferase genetic polymorphisms.
@en
P2093
Christina Justenhoven
Daniel Schaid
J Michael Dixon
James Ingle
Jianping Zhang
Liewei Wang
Michel Eichelbaum
Michelle Hildebrandt
Thomas Brüning
Thomas Sellers
P2860
P304
P356
10.1158/0008-5472.CAN-08-0043
P407
P577
2008-07-01T00:00:00Z